Ziynet ALPHAN ÜÇ, Özgür DEMİR, Suheyla GORAR, Sevim GÜLLÜ

Acromegaly with metastatic renal cell carcinoma: Lung, gluteal and scapular metastasis

The association between acromegaly and increased incidence of malignancy has been reported due to high GH and IGF levels. Although the incidence of all malignancies increases in patients with acromegaly, renal cell carcinoma (RCC) has been rarely reported. Herein, we report an acromegaly case with lung, gluteal and scapular metastatic RCC. The risk of cancer and cancer metastasis is high in uncontrolled acromegaly. At this point, treating acromegaly and controlling the disease progress are both important to enhance the life expectancy of a patient.

PDF

___

Cohen P, Clemmons DR, Rosenfeld RG. Does the GH–IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res. 2000;10:297–305.

Orme SM, McNally RJ, Cartwright RA, et al. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab. 1998;83:2730-4.

Colao A, Ferone D, Marzullo P, et al. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews. 2004;25:102–52.

Escudier B, Szczylik C, Porta C, et al. Treatment selection in metastatic renal cell carcinoma: expert consensus. Nat Rev Clin Oncol. 2012;9:327–37.

Tao Y, Pinzi V, Bourhis J, et al. Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway–therapeutic perspectives in cancer. Nat Clin Pract Oncol. 2007;4:591–602.

Werner H, Shalita-Chesner M, Abramovitch S, Idelman G, ShaharabaniGargir L, Glaser T. Regulation of the insulin-like growth factor-I receptor gene by oncogenes and antioncogenes: implications in human cancer Mol Genet Metab. 2000;71:315–20.

Adam F.Tracz, Szczylik C, Porta C, et al. Czarnecka. Insulin-like growth factor-1 signaling in renal cell carcinoma. BMC Cancer. 2016;16:453.

Nabarro JD. Acromegaly. Clin Endocrinol (Oxf). 1987;26:481-512.

Clayton PE, Banerjee I, Murray PG, et al. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat Rev Endocrinol. 2011;7:11– 24.

Terzolo M, Reimondo G, Berchialla P, et al. Italian Study Group. of Acromegaly. Acromegaly is associated with increased cancer risk: a survey in Italy. EndocrRelat Cancer. 2017;24:495-504.

Rosendahl AH, Forsberg G. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. Kidney Int. 2006;70:1584–90.

Kamenicky P, Mazziotti G, Lombes M, et al. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications. Endocr Rev. 2014;35:234–81.

Parker AS, Cheville JC, Blute ML, et al. Pathologic T1 clear cell renal cell carcinoma: insulin-like growth factor-I receptor expression and diseasespecific survival. Cancer. 2004;100:2577–82.

Sakamoto A, Yoshida T, Matsuura S, et al. Metastasis to the gluteus maximus muscle from renal cell carcinoma with special emphasis on MRI features. World J Surg Oncol. 2007;5:88.